Ushakiran Finance Q1 Results: Net profit rises 18% YoY to ₹8.47 lakh
Ushakiran Finance Limited posted a Q1FY27 net profit of ₹8.47 lakh, recovering from a Q4FY26 loss of ₹8.75 lakh. Revenue grew to ₹19.93 lakh, led by fair value gains. The Board also recommended reappointing director T.R. Sekhar.

*this image is generated using AI for illustrative purposes only.
Ushakiran Finance Limited reported a net profit of ₹8.47 lakh for the quarter ended June 30, 2026 (Q1FY27), rising from ₹7.17 lakh in the same period last year. This turnaround from a loss of ₹8.75 lakh in the preceding quarter highlights the impact of fair value adjustments on its investment portfolio. Total revenue from operations reached ₹19.93 lakh, up from ₹17.76 lakh year-on-year, signaling stability in its core investment income streams.
The Board of Directors approved the unaudited financial results on August 3, 2026, following a review by statutory auditors M/s. NSVR & Associates LLP. The filing was made pursuant to Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In addition to financial approvals, the Board recommended the reappointment of T.R. Sekhar as a Non-Executive Non-Independent Director, subject to shareholder approval at the upcoming Annual General Meeting.
Financial Performance
The company’s revenue structure remains heavily influenced by fair value changes rather than traditional interest or dividend income. While interest income grew modestly to ₹5.26 lakh from ₹4.15 lakh year-on-year, and dividend income increased to ₹1.46 lakh from ₹0.76 lakh, the primary driver of revenue growth was net gain on fair value changes, which stood at ₹13.21 lakh compared to ₹12.85 lakh in Q1FY26.
| Particulars | Q1FY27 (₹ lakh) | Q4FY26 (₹ lakh) | Q1FY26 (₹ lakh) | FY26 (₹ lakh) |
|---|---|---|---|---|
| Interest Income | 5.26 | 5.18 | 4.15 | 18.34 |
| Dividend Income | 1.46 | 1.25 | 0.76 | 10.83 |
| Net Gain on Fair Value | 13.21 | - | 12.85 | 17.71 |
| Total Revenue | 19.93 | 6.43 | 17.76 | 46.88 |
| Total Expenses | 9.60 | 18.46 | 8.93 | 45.53 |
| Net Profit/Loss | 8.47 | (8.75) | 7.17 | (4.36) |
Expenses for the quarter totaled ₹9.60 lakh, a significant decrease from ₹18.46 lakh in Q4FY26. This reduction was largely due to the absence of net losses on fair value changes, which had impacted the previous quarter by ₹12.60 lakh. Employee benefits expense remained stable at ₹3.41 lakh, while other expenses were ₹5.66 lakh.
Corporate Governance Updates
Alongside financial results, the Board addressed key governance matters. It approved the Secretarial Audit Report for the year ended March 31, 2026, and the Directors’ Report with annexures. The 40th Annual General Meeting (AGM) is scheduled for September 29, 2026, to be held via Video Conferencing/Other Audio Visual Means (OAVM). The register of members will remain closed from September 23 to September 29, 2026, with the record date set for September 22, 2026.
Mr. N. Mallikarjuna Rao, Partner at M/s. Mallikarjun Rao and Associates, has been appointed as Scrutinizer for the AGM. The reappointment of T.R. Sekhar, who retires by rotation, is based on recommendations from the Nomination and Remuneration Committee. He currently serves as Executive Director of Sigachi Laboratories Limited and is the son of company director T. Adinarayana.
What the Numbers Show
The volatility in Ushakiran Finance’s quarterly results underscores its dependency on mark-to-market accounting for investments. The swing from a loss of ₹8.75 lakh in Q4FY26 to a profit of ₹8.47 lakh in Q1FY27 is not driven by operational efficiency but by the reversal of fair value losses. With total comprehensive income reaching ₹128.48 lakh, largely due to other comprehensive income items that will not be reclassified to profit or loss, investors should note that the underlying cash-generating ability from interest and dividends remains modest relative to the balance sheet size.
Historical Stock Returns for Ushakiran Finance
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.54% | -9.79% | -12.93% | -42.70% | -14.26% | +175.80% |
How might the company's heavy reliance on fair value adjustments rather than organic interest income affect its valuation stability in volatile market conditions?
What specific investment strategy changes could Ushakiran Finance implement to reduce quarterly earnings volatility caused by mark-to-market accounting?
Will the reappointment of T.R. Sekhar, who holds an executive role at Sigachi Laboratories, raise any concerns regarding potential conflicts of interest or related-party transactions?


































